Home Cart Sign in  
Chemical Structure| 1644545-52-7 Chemical Structure| 1644545-52-7

Structure of Vorasidenib
CAS No.: 1644545-52-7

Chemical Structure| 1644545-52-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Vorasidenib is an isocitrate dehydrogenase (IDH) inhibitor.

Synonyms: AG-881

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Vorasidenib

CAS No. :1644545-52-7
Formula : C14H13ClF6N6
M.W : 414.74
SMILES Code : C[C@@H](NC1=NC(C2=NC(Cl)=CC=C2)=NC(N[C@H](C)C(F)(F)F)=N1)C(F)(F)F
Synonyms :
AG-881
MDL No. :MFCD31630835
InChI Key :QCZAWDGAVJMPTA-RNFRBKRXSA-N
Pubchem ID :117817422

Safety of Vorasidenib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • Dehydrogenase

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice TS603 IDH1-R132H orthotopic glioma model Oral 50 mg/kg Every 12 hours for 4 days To evaluate the inhibition of 2-HG levels in glioma by Vorasidenib, showing >97% inhibition PMC7025383

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT05674474 Hepatic Impairment PHASE1 COMPLETED 2023-07-18 American Research Corporation,... More >> San Antonio, Texas, 78215, United States Less <<
NCT05592743 Glioma|Recurrence|Disease Attr... More >>ibutes|Pathologic Processes|Neoplasms, Neuroepithelial|Neuroectodermal Tumors|Neoplasms, Germ Cell and Embryonal|Neoplasms by Histologic Type|Neoplasms|Neoplasms, Glandular and Epithelial|Neoplasms, Nerve Tissue Less << APPROVED_FOR_MARKETING - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.41mL

0.48mL

0.24mL

12.06mL

2.41mL

1.21mL

24.11mL

4.82mL

2.41mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories